A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying ...

Could a medicine you're already considering for weight loss also lower your risk of dementia, one of the most feared diseases ...

A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal ...

Like, I had all but forgotten that I had written this Time magazine cover story in 2008: A couple things here. One, as the ...

A single seed of the plant is thought to carry the punch of 100 digoxin heart pills.

Supplements for obesity may promise quick results, but the evidence varies. Here’s what research says about the benefits and ...

Breast cancer is the most commonly diagnosed cancer among women worldwide, and its incidence has been rising in many countries, particularly among younger women. Credit: Shutterstock New research ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...